Skip to main content
An exploratory open label phase 1b study of secukinumab in patients with moderate to severe papulopustular rosacea Kumar, A., Chiou, A., Shih, Y., Li, S., Chang, A. ELSEVIER SCIENCE INC. 2019: B15

View details for DOI 10.1016/j.jid.2019.06.071

View details for Web of Science ID 000482187300093